Answers are grounded in this paper and cite their sources.
Introduction.Spinal muscular atrophy (SMA) is a degenerative genetic disorder that primarily affects motor neurons.Disease-modifying therapies have altered the disease's natural course and led to new clinical phenotypes.Recent evidence suggests a systemic impact, including metabolic abnormalities.Objective.To describe the anthropometric, nutritional, and metabolic profiles of children with SMA types 1 and 2 treated at a referral center. Population and methods.We conducted a descriptive cross-sectional study at a tertiary care hospital between 2020 and 2023.We analyzed anthropometric measurements, lipid profile, glucose profile, and nutritional status in 17 children under 12 years of age with type 1 and 2 SMA during their first visit. Results.A high prevalence of overweight, as well as abnormalities in lipid and glucose metabolismincluding insulin resistance-was observed in a significant proportion of patients.An exploratory comparison between type 1 and type 2 SMA revealed a heterogeneous profile: some parameters, such as low HDL and high BMI, were more common in type 1 SMA, while elevated insulin levels were more common in type 2 SMA.These findings do not allow for definitive conclusions regarding differences between subtypes.The only patient treated during the presymptomatic stage had a nutritional and metabolic profile within expected parameters. Conclusion.This study highlights the need for a multidisciplinary approach that includes nutritional and metabolic assessment in the follow-up of patients with SMA, tailored to their new phenotypes and increased life expectancy.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: